Preliminary In Vivo Evidence of Oral Selenium Supplementation as a Potentiating Agent on a Vector-Based COVID-19 Vaccine in BALB/c Mice

Evidence of efficacy and toxicity of oral selenium supplementation in vaccine administration against severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) in mice models is scarce. In this study, 4 × 10(9) virus particles (40 µL) dose of Janssen COVID-19 intramuscular injection vaccine was su...

Descripción completa

Detalles Bibliográficos
Autores principales: Mudenda, Muunda, Kimani, Josephine, Kinyua, Johnson, Kimotho, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863471/
https://www.ncbi.nlm.nih.gov/pubmed/36679902
http://dx.doi.org/10.3390/vaccines11010057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863471/
https://www.ncbi.nlm.nih.gov/pubmed/36679902
http://dx.doi.org/10.3390/vaccines11010057

Ejemplares similares